Back to search
FDAFDA · Food and drugs·Recall number D-0315-2025

Propafenone Hydrochloride Extended-Release Capsules 225mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-408-60

Published April 16, 2025 · Recall initiated: March 13, 2025

Summary

FDA records drug Class II recall D-0315-2025, published April 16, 2025 and initiated March 13, 2025. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Ongoing; Reported quantity: N/A; Lot: Lot # 17230819, exp. date Mar-25. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if PROPAFENONE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PROPAFENONE HYDROCHLORIDE
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Distributor
U.S. Nationwide
UPC
0368462409602
Lot
Lot # 17230819, exp. date Mar-25
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Propafenone Hydrochloride Extended-Release Capsules 225mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-408-60 recalled?

Yes. FDA published recall D-0315-2025 on April 16, 2025. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PROPAFENONE HYDROCHLORIDE. UPC: 0368462409602.